New hookworm vaccine shows promise in early human trial

NCT ID NCT03172975

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new vaccine to prevent hookworm infection in 39 healthy adults who had never had hookworms before. Participants received different versions of the vaccine and were then exposed to hookworms in a controlled setting to see if the vaccine could prevent infection. The goal was to check safety and how well the vaccine triggers the immune system to fight off the parasite.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HOOKWORM INFECTIONS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • George Washington University

    Washington D.C., District of Columbia, 20037, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.